Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04360928 · ClinicalTrials.gov registry record · NA
Knee Split Comparison After ACL Reconstruction
A NA study, sponsored by Rush University Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT04360928 is a NA study that was terminated before completion, run by Rush University Medical Center. The registered enrollment target is 21 participants.
The verdict
NCT04360928, a NA study, was terminated before completion, sponsored by Rush University Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
This study will evaluate the efficacy of the Graymont X ERIS Knee Splint brace in the postoperative period of ACL reconstruction to improve range of motion, specifically the achievement of terminal extension and time-to-achievement compared to the standard hinged knee brace. This will be directly measured with goniometric angle and heel-height measurements relative to the contralateral side. Other metrics will include standard, validated patient reported outcomes and requirements for additional interventions to treat extension deficits including, but not limited to, additional therapy, intraarticular injections, oral corticosteroids, manipulation under anesthesia, or arthroscopic arthrolysis.
Interventions
- DEVICE Graymont X ERIS Knee Splint
- DEVICE Standard Hinge Knee Brace
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2023-08-01 |
| Est. Completion | 2025-01-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04360928
The ClinicalTrials.gov registry entry for NCT04360928 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rush University Medical Center, which has 320 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Graymont X ERIS Knee Splint is the first listed.
NCT04360928 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04360928 about?
NCT04360928 is a clinical study titled "Knee Split Comparison After ACL Reconstruction". This study will evaluate the efficacy of the Graymont X ERIS Knee Splint brace in the postoperative period of ACL reconstruction to improve range of motion, specifically the achievement of terminal extension and time-to-achievement compared to the standard hinged knee brace. This will be directly me...
What is the current status of trial NCT04360928?
This trial is currently terminated. It is a NA study. The enrollment target is 21 participants. The study started on 2023-08-01. Estimated completion is 2025-01-06.
What interventions are being tested in trial NCT04360928?
The interventions under investigation include: Graymont X ERIS Knee Splint (DEVICE), Standard Hinge Knee Brace (DEVICE).
Who is sponsoring clinical trial NCT04360928?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.